TF and Alzheimer disease: TF is considered a potential source of biomarker molecules; recent studies have reported that in systemic diseases such as AD, disease-altered protein expression can be detected in TF samples (Yaqub et al. 2023; Kalló et al. 2016; Król-Grzymała et al. 2022; Gijs et al. 2021).